We have examined the effects of the cannabinoid anandamide (AEA) and its stable analog, methanandamide (methAEA), on large-conductance, Ca 2ϩ -activated K ϩ (BK) channels using human embryonic kidney (HEK)-293 cells, in which the ␣-subunit of the BK channel (BK-␣), both ␣-and  1-subunits (BK-␣1), or both ␣-and 4-subunits (BK-␣4) were heterologously expressed. In a whole cell voltage-clamp configuration, each cannabinoid activated BK-␣ 1 within a similar concentration range. Because methAEA could potentiate BK-␣, BK-␣ 1, and BK-␣4 with similar efficacy, the -subunits may not be involved at the site of action for cannabinoids. Under cell-attached patch-clamp conditions, application of methAEA to the bathing solution increased BK channel activity; however, methAEA did not alter channel activity in the excised inside-out patch mode even when ATP was present on the cytoplasmic side of the membrane. Application of methAEA to HEK-BK-␣ and HEK-BK-␣ 1 did not change intracellular Ca 2ϩ concentration. Moreover, methAEA-induced potentiation of BK channel currents was not affected by pretreatment with a CB 1 antagonist (AM251), modulators of G proteins (cholera and pertussis toxins) or by application of a selective CB 2 agonist (JWH133). Inhibitors of CaM, PKG, and MAPKs (W7, KT5823, and PD-98059) did not affect the potentiation. Application of methAEA to mouse aortic myocytes significantly increased BK channel currents. This study provides the first direct evidence that unknown factors in the cytoplasm mediate the ability of endogenous cannabinoids to activate BK channel currents. Cannabinoids may be hyperpolarizing factors in cells, such as arterial myocytes, in which BK channels are highly expressed.anandamide; channel opener LARGE-CONDUCTANCE Ca 2ϩ -activated K ϩ (BK) channels consist of channel-forming ␣-subunit and accessory -subunits ( 1 - 4 ) arranged in tetramers (24). Each -subunit interacts with the NH 2 -terminal region of the ␣-subunit and regulates the activity of the ␣-subunit by changing Ca 2ϩ and voltage sensitivity and/or channel kinetics (10, 11). Although only one major type of ␣-subunit with splice variants has been found, several subtypes of -subunits whose  1 -and  4 -isoforms are abundantly expressed in smooth muscle and central nervous system (CNS), respectively, have been cloned and may be responsible for the tissue-specific characteristics of BK channels (4,36,44). Synthetic compounds such as NS-1619 and BMS-204352 are activators of the BK-␣ subunit, whereas dehydrosoyasaponin I (14), 17-estradiol (37, 3), and tamoxifen (9) act on the BK  1 -subunit. Agents that enhance BK channel activity (BK channel openers) may be effective in protecting neurons from damage after an ischemic stroke and/or in suppressing excess activity of smooth muscle tissues (23, 35). 17-Estradiol (37), arachidonic acid (AA) (21), epoxyeicosatrienoic acids (EETs) (13), and dihydroxyeicosatrienoic acids (25) may be endogenous BK channel openers, and some transmitters and hormones also can enhance BK channel ...